73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Response to neoadjuvant chemo for breast cancer varies by sex

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, acco

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, acco
American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainA newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on

American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainA newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on
As medical debt rises, so do cancer death rates

As medical debt rises, so do cancer death rates

by Dennis ThompsonFolks who are loaded down with medical debt are less likely to survive a bout of cancer, a new study reports.Researchers found that U.S. counties where more residents have medical de

As medical debt rises, so do cancer death rates

by Dennis ThompsonFolks who are loaded down with medical debt are less likely to survive a bout of cancer, a new study reports.Researchers found that U.S. counties where more residents have medical de
Starting cancer treatment? You should discuss fertility first

Starting cancer treatment? You should discuss fertility first

by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi

Starting cancer treatment? You should discuss fertility first

by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Prozac fights deadly childhood brain cancer

Prozac fights deadly childhood brain cancer

by Hayley Jarvis,Brunel UniversityKiller T cells surround a cancer cell. Credit: NIHThe anti-depressant drug Prozac could be used to tackle one of the deadliest childhood tumours and possibly ot

Prozac fights deadly childhood brain cancer

by Hayley Jarvis,Brunel UniversityKiller T cells surround a cancer cell. Credit: NIHThe anti-depressant drug Prozac could be used to tackle one of the deadliest childhood tumours and possibly ot
Improving drug therapy for relapsed leukemia

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a
Refined method to peer into cancer cells' inner working unlocks the interactome

Refined method to peer into cancer cells' inner working unlocks the interactome

byJosep Carreras Leukaemia Research InstituteliCHi-C identifies cell types presumably implicated in disease etiology. A Enrichment of GWAS summary statistics at promoter-interacting regions (PIR

Refined method to peer into cancer cells' inner working unlocks the interactome

byJosep Carreras Leukaemia Research InstituteliCHi-C identifies cell types presumably implicated in disease etiology. A Enrichment of GWAS summary statistics at promoter-interacting regions (PIR
Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in
How dangerous is it for lung cancer patients to skip radiation treatments?

How dangerous is it for lung cancer patients to skip radiation treatments?

by Cara MurezAs doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a highe

How dangerous is it for lung cancer patients to skip radiation treatments?

by Cara MurezAs doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a highe
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MDPrithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal tr

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MDPrithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal tr